Laxiriva Med Appelsin/Sitrussmak

Sodium hydrogen carbonate, potassium chloride, sodium chloride and macrogol 3350, the active ingredients in Laxiriva Med Appelsin/Sitrussmak, are an osmotic laxative presented as an oral solution for oral use. It is indicated for the relief of constipation in adults and children when a gentle, water‑based bowel‑cleansing action is required.

GNH USA supplies Laxiriva Med Appelsin/Sitrussmak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution, ensuring product integrity throughout the supply chain.

Laxiriva Med is an osmotic laxative used to manage conditions characterized by difficult stool passage.

Constipation: softens stool and promotes regular bowel movements. Chronic constipation: provides sustained hydration of the intestinal lumen to aid long‑term relief. Functional constipation: improves stool frequency and reduces straining during defecation.

Laxiriva Med may be associated with several adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: mild distension of the abdomen. - Flatulence: increased intestinal gas. - Nausea: feeling of queasiness. - Diarrhea: loose, watery stools.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium, potassium or chloride levels. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before initiating therapy, consider the following precautions to ensure safe use.

Assess renal function: ensure adequate kidney function before use. Monitor fluid intake: maintain sufficient hydration to support osmotic activity. Use with caution in electrolyte disorders: patients with hypernatremia or hypokalemia need evaluation. Avoid prolonged use: limit duration to prevent dependence or electrolyte shifts. Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture.

Laxiriva Med can interact with other medicines; awareness of potential interactions helps maintain safety.

Major Interactions (Avoid): - Concomitant use with other osmotic laxatives: may cause excessive fluid loss and electrolyte imbalance. - High-dose mineral supplements (e.g., potassium chloride): can exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Antacids containing sodium bicarbonate: may alter electrolyte composition. - Diuretics: monitor for additive fluid loss. - Certain antibiotics (e.g., quinolones): reduced absorption due to altered gastrointestinal transit.